Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday, 2nd November, 2026, inter-alia, to consider and approve the Un-audited Financial Results (Standalone ....

Ref. No.: WOCK/SEC/SE/2026-27/042 27th October, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers Bandra Kurla Complex Dalal Street Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 532300 NSE Symbol: WOCKPHARMA Dear Sir/Madam, Subject: Intimation of the Meeting of Board of Directors of Wockhardt Limited (‘the Company’) Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday, 2nd November, 2026, inter-alia, to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September, 2026. In view of the above, the trading window for dealing in the shares of the Company, which was closed from Thursday, 1st October, 2026 shall remain closed until 48 hours after the declaration of Financial Results on 2nd November, 2026. Kindly take the above information on record. Thanking you, For Wockhardt Limited Rashmi Mamtura Company Secretary